title: Number needed to treat to harm for discontinuation due to adverse events in the treatment of bipolar depression, major depressive disorder, and generalized anxiety disorder with atypical antipsychotics.
authors.affiliation: Department of Psychiatry, Mood and Anxiety Clinic in the Mood Disorders Program, University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA. keming.gao@uhhospitals.org
authors.forename: Keming
authors.initials: K
authors.lastname: Gao
authors.forename: David E
authors.initials: DE
authors.lastname: Kemp
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Fein
authors.forename: Zuowei
authors.initials: Z
authors.lastname: Wang
authors.forename: Yiru
authors.initials: Y
authors.lastname: Fang
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Ganocy
authors.forename: Joseph R
authors.initials: JR
authors.lastname: Calabrese
mesh_terms: D016907:Adverse Drug Reaction Reporting Systems; D017109:Akathisia, Drug-Induced / Q000209:etiology; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D001714:Bipolar Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D003692:Delayed-Action Preparations; D003865:Major Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000523:psychology; D006970:Disorders of Excessive Somnolence / Q000139:chemically induced; D004305:Dose-Response Relationship, Drug; D057915:Drug Substitution; D006801:Humans; D011358:Product Surveillance, Postmarketing; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D014851:Wakefulness / Q000187:drug effects; D015430:Weight Gain / Q000187:drug effects
chemical_list: D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations